A matched analysis of the use of high flow nasal cannula for pediatric severe acute asthma
Encounters using HFNC for severe acute pediatric asthma had decreased clinical improvement in 24 h of hospitalization compared to matched controls and increased LOS. Specific subgroups of younger patients and those with the highest severity scores showed no differences in clinical symptom improvement suggesting differential effects in specific patient populations.
Authors
- Samer Abu‐Sultaneh (ORCID: https://orcid.org/0000-0002-2659-2070)
- Sarah E. Wiehe (ORCID: https://orcid.org/0000-0002-8148-0848)
- Eneida A. Mendonça (ORCID: https://orcid.org/0000-0003-4297-9221)
- L. Nelson Sanchez‐Pinto (ORCID: https://orcid.org/0000-0002-7434-6747)
- Wanzhu Tu (ORCID: https://orcid.org/0000-0002-4236-9135)
- Colin Rogerson (ORCID: https://orcid.org/0000-0001-5251-2399)
- Benjamin M Gaston (ORCID: https://orcid.org/0000-0001-8794-1062)
- Titus Schleyer (ORCID: https://orcid.org/0000-0003-1829-971X)
Institutions
- Northwestern University (US)
- Cincinnati Children's Hospital Medical Center (US)
- Lurie Children's Hospital (US)
- Regenstrief Institute (US)
- Children's Hospital & Medical Center (US)
- Indiana University School of Medicine
- Indiana University (US)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1002/ppul.27233
- Citations
- 4
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.31